Evidence map›Paper›PMID 20923771›Full record

ArticleThe Journal of biological chemistry2010

A mouse macrophage lipidome.

Edward A Dennis, Raymond A Deems, Richard Harkewicz, Oswald Quehenberger, H Alex Brown, Stephen B Milne, David S Myers, Christopher K Glass, Gary Hardiman, Donna Reichart and 18 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 167 papers.

0numbers the graph read from it
0cells of the map it votes in
167citing papers in PubMed
23.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

167 citing papers in PubMed, 315 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

107 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 9 institutions in 1 country.

Edward A DennisDepartment of Chemistry and Biochemistry, School of Medicine, University of California, San Diego, La Jolla, California 92093, USA. edennis@ucsd.edu
Raymond A Deems
Richard Harkewicz
Oswald Quehenberger
H Alex Brown
Stephen B Milne
David S Myers
Christopher K Glass
Gary Hardiman
Donna Reichart
Alfred H Merrill
M Cameron Sullards
Elaine Wang
Robert C Murphy
Christian R H Raetz
Teresa A Garrett
Ziqiang Guan
Andrea C Ryan
David W Russell
Jeffrey G McDonald
Bonne M Thompson
Walter A Shaw
Manish Sud
Yihua Zhao
Shakti Gupta
Mano R Maurya
Eoin Fahy
Shankar Subramaniam
University of California, San Diego · USDuke University Hospital · USGeorgia Institute of Technology · USSan Diego Supercomputer Center · USThe University of Texas Southwestern Medical Center · USVanderbilt University · USAvanti Polar Lipids (United States) · USDuke Medical Center · USUniversity of Colorado Denver · US

Funding

STEROL LIPIDSU54GM069338 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DENNIS, EDWARD A · 2003 to 2013
$72.2M
NIGMS NIH HHS U54 GM069338NIGMS NIH HHS U54GM069338
6 · The paper itself

Abstract

We report the lipidomic response of the murine macrophage RAW cell line to Kdo(2)-lipid A, the active component of an inflammatory lipopolysaccharide functioning as a selective TLR4 agonist and compactin, a statin inhibitor of cholesterol biosynthesis. Analyses of lipid molecular species by dynamic quantitative mass spectrometry and concomitant transcriptomic measurements define the lipidome and demonstrate immediate responses in fatty acid metabolism represented by increases in eicosanoid synthesis and delayed responses characterized by sphingolipid and sterol biosynthesis. Lipid remodeling of glycerolipids, glycerophospholipids, and prenols also take place, indicating that activation of the innate immune system by inflammatory mediators leads to alterations in a majority of mammalian lipid categories, including unanticipated effects of a statin drug. Our studies provide a systems-level view of lipid metabolism and reveal significant connections between lipid and cell signaling and biochemical pathways that contribute to innate immune responses and to pharmacological perturbations.

Indexed as

Immunity, InnateLipid MetabolismAnimalsCell LineInflammation MediatorsLipopolysaccharidesMacrophagesMiceToll-Like Receptor 4Inflammation MediatorsKdo2-lipid ALipopolysaccharidesTlr4 protein, mouseToll-Like Receptor 4

Identifiers

PMID20923771
PMCPMC3000979
OpenAlexW2122326381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.